[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
May 19, 1999

Incomplete Financial Disclosure and Incorrect Numbers

JAMA. 1999;281(19):1795. doi:10.1001/jama.281.19.1795

In the Preliminary Communication entitled "Percutaneous Electrical Nerve Stimulation for Low Back Pain: A Randomized Crossover Study," published in the March 3, 1999, issue of THE JOURNAL (1999;281:818-823), a potential financial conflict was not revealed. One month after submission of their manuscript to JAMA, Drs White and Craig incorporated a company named PENS Inc to produce a Food and Drug Administration–approvable stimulating unit to provide percutaneous electrical nerve stimulation (PENS) therapy. Drs White and Craig completed their financial disclosure statements at the time of submission but these disclosure statements were not updated after the company was incorporated.

Also, on page 819, under the heading "Methods," "mean ± SD age, 43 ± 1.9 years, and weight, 66 ± 1.6 kg" should have read 43 ± 19 years and 66 ± 16 kg.

×